img

Global Artesunate Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Artesunate Drugs Market Insights, Forecast to 2034

Artesunate (AS) is a medication used to treat malaria. The intravenous form is preferred to quinidine for severe malaria. Often it is used as part of combination therapy. It is not used for the prevention of malaria.
Market Analysis and InsightsGlobal Artesunate Drugs Market
Global Artesunate Drugs market is expected to reach to US$ 183 million in 2024, with a positive growth of %, compared with US$ 168 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Artesunate Drugs industry is evaluated to reach US$ 277.7 million in 2029. The CAGR will be 7.2% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Artesunate Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Artesunate Drugs market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Fosun Pharma (Guilin)
Ipca Laboratories
Sanofi Aventis
Ajanta Pharma
Shin Poong
Cipla
Acino
MCW Healthcare
Segment by Type
Monoaromatic Artesunate
Compound Artesunate

Segment by Application


Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Artesunate Drugs introduction, etc. Artesunate Drugs Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Artesunate Drugs
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artesunate Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoaromatic Artesunate
1.2.3 Compound Artesunate
1.3 Market by Application
1.3.1 Global Artesunate Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artesunate Drugs Market Perspective (2018-2029)
2.2 Global Artesunate Drugs Growth Trends by Region
2.2.1 Artesunate Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artesunate Drugs Historic Market Size by Region (2018-2024)
2.2.3 Artesunate Drugs Forecasted Market Size by Region (2024-2029)
2.3 Artesunate Drugs Market Dynamics
2.3.1 Artesunate Drugs Industry Trends
2.3.2 Artesunate Drugs Market Drivers
2.3.3 Artesunate Drugs Market Challenges
2.3.4 Artesunate Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Artesunate Drugs by Players
3.1.1 Global Artesunate Drugs Revenue by Players (2018-2024)
3.1.2 Global Artesunate Drugs Revenue Market Share by Players (2018-2024)
3.2 Global Artesunate Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Artesunate Drugs, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Artesunate Drugs Market Concentration Ratio
3.4.1 Global Artesunate Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artesunate Drugs Revenue in 2022
3.5 Global Key Players of Artesunate Drugs Head office and Area Served
3.6 Global Key Players of Artesunate Drugs, Product and Application
3.7 Global Key Players of Artesunate Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Artesunate Drugs Breakdown Data by Type
4.1 Global Artesunate Drugs Historic Market Size by Type (2018-2024)
4.2 Global Artesunate Drugs Forecasted Market Size by Type (2024-2029)
5 Artesunate Drugs Breakdown Data by Application
5.1 Global Artesunate Drugs Historic Market Size by Application (2018-2024)
5.2 Global Artesunate Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artesunate Drugs Market Size (2018-2029)
6.2 North America Artesunate Drugs Market Size by Type
6.2.1 North America Artesunate Drugs Market Size by Type (2018-2024)
6.2.2 North America Artesunate Drugs Market Size by Type (2024-2029)
6.2.3 North America Artesunate Drugs Market Share by Type (2018-2029)
6.3 North America Artesunate Drugs Market Size by Application
6.3.1 North America Artesunate Drugs Market Size by Application (2018-2024)
6.3.2 North America Artesunate Drugs Market Size by Application (2024-2029)
6.3.3 North America Artesunate Drugs Market Share by Application (2018-2029)
6.4 North America Artesunate Drugs Market Size by Country
6.4.1 North America Artesunate Drugs Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Artesunate Drugs Market Size by Country (2018-2024)
6.4.3 North America Artesunate Drugs Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Artesunate Drugs Market Size (2018-2029)
7.2 Europe Artesunate Drugs Market Size by Type
7.2.1 Europe Artesunate Drugs Market Size by Type (2018-2024)
7.2.2 Europe Artesunate Drugs Market Size by Type (2024-2029)
7.2.3 Europe Artesunate Drugs Market Share by Type (2018-2029)
7.3 Europe Artesunate Drugs Market Size by Application
7.3.1 Europe Artesunate Drugs Market Size by Application (2018-2024)
7.3.2 Europe Artesunate Drugs Market Size by Application (2024-2029)
7.3.3 Europe Artesunate Drugs Market Share by Application (2018-2029)
7.4 Europe Artesunate Drugs Market Size by Country
7.4.1 Europe Artesunate Drugs Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Artesunate Drugs Market Size by Country (2018-2024)
7.4.3 Europe Artesunate Drugs Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Artesunate Drugs Market Size (2018-2029)
8.2 China Artesunate Drugs Market Size by Type
8.2.1 China Artesunate Drugs Market Size by Type (2018-2024)
8.2.2 China Artesunate Drugs Market Size by Type (2024-2029)
8.2.3 China Artesunate Drugs Market Share by Type (2018-2029)
8.3 China Artesunate Drugs Market Size by Application
8.3.1 China Artesunate Drugs Market Size by Application (2018-2024)
8.3.2 China Artesunate Drugs Market Size by Application (2024-2029)
8.3.3 China Artesunate Drugs Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Artesunate Drugs Market Size (2018-2029)
9.2 Asia Artesunate Drugs Market Size by Type
9.2.1 Asia Artesunate Drugs Market Size by Type (2018-2024)
9.2.2 Asia Artesunate Drugs Market Size by Type (2024-2029)
9.2.3 Asia Artesunate Drugs Market Share by Type (2018-2029)
9.3 Asia Artesunate Drugs Market Size by Application
9.3.1 Asia Artesunate Drugs Market Size by Application (2018-2024)
9.3.2 Asia Artesunate Drugs Market Size by Application (2024-2029)
9.3.3 Asia Artesunate Drugs Market Share by Application (2018-2029)
9.4 Asia Artesunate Drugs Market Size by Region
9.4.1 Asia Artesunate Drugs Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Artesunate Drugs Market Size by Region (2018-2024)
9.4.3 Asia Artesunate Drugs Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Artesunate Drugs Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Type
10.2.1 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Artesunate Drugs Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Application
10.3.1 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Artesunate Drugs Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Country
10.4.1 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Artesunate Drugs Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Fosun Pharma (Guilin)
11.1.1 Fosun Pharma (Guilin) Company Details
11.1.2 Fosun Pharma (Guilin) Business Overview
11.1.3 Fosun Pharma (Guilin) Artesunate Drugs Introduction
11.1.4 Fosun Pharma (Guilin) Revenue in Artesunate Drugs Business (2018-2024)
11.1.5 Fosun Pharma (Guilin) Recent Developments
11.2 Ipca Laboratories
11.2.1 Ipca Laboratories Company Details
11.2.2 Ipca Laboratories Business Overview
11.2.3 Ipca Laboratories Artesunate Drugs Introduction
11.2.4 Ipca Laboratories Revenue in Artesunate Drugs Business (2018-2024)
11.2.5 Ipca Laboratories Recent Developments
11.3 Sanofi Aventis
11.3.1 Sanofi Aventis Company Details
11.3.2 Sanofi Aventis Business Overview
11.3.3 Sanofi Aventis Artesunate Drugs Introduction
11.3.4 Sanofi Aventis Revenue in Artesunate Drugs Business (2018-2024)
11.3.5 Sanofi Aventis Recent Developments
11.4 Ajanta Pharma
11.4.1 Ajanta Pharma Company Details
11.4.2 Ajanta Pharma Business Overview
11.4.3 Ajanta Pharma Artesunate Drugs Introduction
11.4.4 Ajanta Pharma Revenue in Artesunate Drugs Business (2018-2024)
11.4.5 Ajanta Pharma Recent Developments
11.5 Shin Poong
11.5.1 Shin Poong Company Details
11.5.2 Shin Poong Business Overview
11.5.3 Shin Poong Artesunate Drugs Introduction
11.5.4 Shin Poong Revenue in Artesunate Drugs Business (2018-2024)
11.5.5 Shin Poong Recent Developments
11.6 Cipla
11.6.1 Cipla Company Details
11.6.2 Cipla Business Overview
11.6.3 Cipla Artesunate Drugs Introduction
11.6.4 Cipla Revenue in Artesunate Drugs Business (2018-2024)
11.6.5 Cipla Recent Developments
11.7 Acino
11.7.1 Acino Company Details
11.7.2 Acino Business Overview
11.7.3 Acino Artesunate Drugs Introduction
11.7.4 Acino Revenue in Artesunate Drugs Business (2018-2024)
11.7.5 Acino Recent Developments
11.8 MCW Healthcare
11.8.1 MCW Healthcare Company Details
11.8.2 MCW Healthcare Business Overview
11.8.3 MCW Healthcare Artesunate Drugs Introduction
11.8.4 MCW Healthcare Revenue in Artesunate Drugs Business (2018-2024)
11.8.5 MCW Healthcare Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Artesunate Drugs Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Monoaromatic Artesunate
Table 3. Key Players of Compound Artesunate
Table 4. Global Artesunate Drugs Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Artesunate Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Artesunate Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Artesunate Drugs Market Share by Region (2018-2024)
Table 8. Global Artesunate Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Artesunate Drugs Market Share by Region (2024-2029)
Table 10. Artesunate Drugs Market Trends
Table 11. Artesunate Drugs Market Drivers
Table 12. Artesunate Drugs Market Challenges
Table 13. Artesunate Drugs Market Restraints
Table 14. Global Artesunate Drugs Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Artesunate Drugs Revenue Share by Players (2018-2024)
Table 16. Global Top Artesunate Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Drugs as of 2022)
Table 17. Global Artesunate Drugs Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Artesunate Drugs Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Artesunate Drugs, Headquarters and Area Served
Table 20. Global Key Players of Artesunate Drugs, Product and Application
Table 21. Global Key Players of Artesunate Drugs, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Artesunate Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Artesunate Drugs Revenue Market Share by Type (2018-2024)
Table 25. Global Artesunate Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Artesunate Drugs Revenue Market Share by Type (2024-2029)
Table 27. Global Artesunate Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Artesunate Drugs Revenue Share by Application (2018-2024)
Table 29. Global Artesunate Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Artesunate Drugs Revenue Share by Application (2024-2029)
Table 31. North America Artesunate Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Artesunate Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Artesunate Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Artesunate Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Artesunate Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Artesunate Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Artesunate Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Artesunate Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Artesunate Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Artesunate Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Artesunate Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Artesunate Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Artesunate Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Artesunate Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Artesunate Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Artesunate Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Artesunate Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Artesunate Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Artesunate Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Artesunate Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Artesunate Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Artesunate Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Artesunate Drugs Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Artesunate Drugs Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Artesunate Drugs Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Artesunate Drugs Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Artesunate Drugs Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Artesunate Drugs Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Artesunate Drugs Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Artesunate Drugs Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Artesunate Drugs Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Artesunate Drugs Market Size by Country (2024-2029) & (US$ Million)
Table 63. Fosun Pharma (Guilin) Company Details
Table 64. Fosun Pharma (Guilin) Business Overview
Table 65. Fosun Pharma (Guilin) Artesunate Drugs Product
Table 66. Fosun Pharma (Guilin) Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 67. Fosun Pharma (Guilin) Recent Developments
Table 68. Ipca Laboratories Company Details
Table 69. Ipca Laboratories Business Overview
Table 70. Ipca Laboratories Artesunate Drugs Product
Table 71. Ipca Laboratories Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 72. Ipca Laboratories Recent Developments
Table 73. Sanofi Aventis Company Details
Table 74. Sanofi Aventis Business Overview
Table 75. Sanofi Aventis Artesunate Drugs Product
Table 76. Sanofi Aventis Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 77. Sanofi Aventis Recent Developments
Table 78. Ajanta Pharma Company Details
Table 79. Ajanta Pharma Business Overview
Table 80. Ajanta Pharma Artesunate Drugs Product
Table 81. Ajanta Pharma Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 82. Ajanta Pharma Recent Developments
Table 83. Shin Poong Company Details
Table 84. Shin Poong Business Overview
Table 85. Shin Poong Artesunate Drugs Product
Table 86. Shin Poong Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 87. Shin Poong Recent Developments
Table 88. Cipla Company Details
Table 89. Cipla Business Overview
Table 90. Cipla Artesunate Drugs Product
Table 91. Cipla Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 92. Cipla Recent Developments
Table 93. Acino Company Details
Table 94. Acino Business Overview
Table 95. Acino Artesunate Drugs Product
Table 96. Acino Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 97. Acino Recent Developments
Table 98. MCW Healthcare Company Details
Table 99. MCW Healthcare Business Overview
Table 100. MCW Healthcare Artesunate Drugs Product
Table 101. MCW Healthcare Revenue in Artesunate Drugs Business (2018-2024) & (US$ Million)
Table 102. MCW Healthcare Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Artesunate Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Artesunate Drugs Market Share by Type: 2022 VS 2029
Figure 3. Monoaromatic Artesunate Features
Figure 4. Compound Artesunate Features
Figure 5. Global Artesunate Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Artesunate Drugs Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Other Case Studies
Figure 10. Artesunate Drugs Report Years Considered
Figure 11. Global Artesunate Drugs Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Artesunate Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Artesunate Drugs Market Share by Region: 2022 VS 2029
Figure 14. Global Artesunate Drugs Market Share by Players in 2022
Figure 15. Global Top Artesunate Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artesunate Drugs as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Artesunate Drugs Revenue in 2022
Figure 17. North America Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Artesunate Drugs Market Share by Type (2018-2029)
Figure 19. North America Artesunate Drugs Market Share by Application (2018-2029)
Figure 20. North America Artesunate Drugs Market Share by Country (2018-2029)
Figure 21. United States Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Artesunate Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Artesunate Drugs Market Share by Type (2018-2029)
Figure 25. Europe Artesunate Drugs Market Share by Application (2018-2029)
Figure 26. Europe Artesunate Drugs Market Share by Country (2018-2029)
Figure 27. Germany Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Artesunate Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Artesunate Drugs Market Share by Type (2018-2029)
Figure 35. China Artesunate Drugs Market Share by Application (2018-2029)
Figure 36. Asia Artesunate Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Artesunate Drugs Market Share by Type (2018-2029)
Figure 38. Asia Artesunate Drugs Market Share by Application (2018-2029)
Figure 39. Asia Artesunate Drugs Market Share by Region (2018-2029)
Figure 40. Japan Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Artesunate Drugs Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Artesunate Drugs Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Artesunate Drugs Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Artesunate Drugs Market Share by Country (2018-2029)
Figure 50. Brazil Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Artesunate Drugs Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Fosun Pharma (Guilin) Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 57. Ipca Laboratories Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 58. Sanofi Aventis Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 59. Ajanta Pharma Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 60. Shin Poong Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 61. Cipla Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 62. Acino Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 63. MCW Healthcare Revenue Growth Rate in Artesunate Drugs Business (2018-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed